HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of HealthEquity (NASDAQ:HQY) from a hold rating to a buy rating in a report published on Saturday,Wall Street Zen reports.

Several other research firms have also weighed in on HQY. Deutsche Bank Aktiengesellschaft lifted their target price on HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a report on Monday, August 31st. BTIG Research restated a “buy” rating and issued a $115.00 price target on shares of HealthEquity in a report on Friday, August 28th. Barclays increased their price target on HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, September 18th. Telsey Advisory Group set a $111.00 price target on HealthEquity in a research report on Friday, August 28th. Finally, Raymond James Financial reiterated a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $112.20.

HealthEquity Price Performance

Shares of HQY stock opened at $92.03 on Friday. The stock has a 50-day moving average price of $97.13 and a 200 day moving average price of $91.22. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. The firm has a market cap of $7.61 billion, a price-to-earnings ratio of 33.22, a PEG ratio of 1.46 and a beta of 0.24. HealthEquity has a 12 month low of $72.76 and a 12 month high of $107.62.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.19 by $0.05. The company had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Research analysts expect that HealthEquity will post 3.93 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the company’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the sale, the director directly owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Large investors have recently modified their holdings of the stock. Leonteq Securities AG increased its stake in HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the period. Silvant Capital Management LLC bought a new stake in HealthEquity during the 2nd quarter valued at about $35,000. Axiom Investment Management LLC bought a new stake in HealthEquity during the 1st quarter valued at about $33,000. Public Employees Retirement System of Ohio purchased a new stake in HealthEquity in the 2nd quarter valued at about $39,000. Finally, Caitong International Asset Management Co. Ltd boosted its position in HealthEquity by 2,476.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 421 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) provides technology-enabled services for consumer-directed health and benefits accounts. The company administers health savings accounts (HSAs) and offers related products such as flexible spending accounts, health reimbursement arrangements, commuter benefits and other employee benefit programs.

Its platform is designed to help employers, benefits advisors, health plans and individuals manage benefits, make healthcare payments, access account information and invest eligible HSA funds.